Oncology

The Center for Health Value Innovation (CHVI) presented a webinar yesterday that touched on clinical pathways for oncology and how value-based approaches will help to improve health and financial outcomes.

Getting On Pathway?

Signaling the Future of Personalized Medicine

Money Well Spent?

SABCS Conference Coverage

This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.

Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy

Availability of Newer Agents May Lower Healthcare Costs

Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology

UPMC Oncologists: Pioneers in the Clinical Pathways Movement

Use of bioimpedance spectroscopy to aid in post“breast cancer assessments for lymphedema can be cost saving for healthcare organizations in the United States.

Many primary care physicians - and even some oncologists - are unaware of common long-term side effects of four widely used breast and colorectal cancer drugs, a national survey by the National Cancer Institute reveals.

A statewide collaboration between payers and providers to create a cancer clinical care pathways program is successful.

It is not just 1 physician who cares for a patient enrolled onto a clinical trial but rather a complex system of several physician teams, sometimes with very different opinions, who must work together for therapy to be successful and for the patient to have faith in his treating team.